To understand where GLP1 is headed and what it means for manufacturers and retailers, we spoke with Leigh ODonnell, GLP1 expert and sponsor of Kantars Global GLP1 study, about the drivers behind its growth, how consumer behavior is changing, and why this shift is only just beginning
However, if you have been at maximum dose for 12 or more weeks without adequate response, or if side effects prevent further dose increases, switching to tirzepatide is a reasonable next step
Notably, tirzepatide can reduce oral contraceptive exposure, and backup non-oral or barrier contraception is recommended for 4 weeks after initiation and each dose increase
Each treatment plan begins with a provider consultation to ensure the safest and most effective path forward for your personal health goals
Molecular responses to stress induced in normal human caucasian melanocytes in culture by exposure to simulated solar UV
This product is not intended for human consumption, veterinary use, clinical use, treatment, diagnosis, prevention, cosmetic use, skincare use, supplement use, body composition use or any form of personal use
